FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease

(MedPage Today) — The first FDA-approved treatment option for Sjögren’s disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data.
B-cell activation in Sjögren’s disease results in immunoglobulin…

Source link : https://www.medpagetoday.com/spotlight/acr-sjogrens-syndrome/119151

Author :

Publish date : 2025-12-23 13:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

FcRn Blockers Vie to Become First Approved Drug for Sjogren’s Disease

EU Calls for Heart Health Plans Amid Rising Disease Burden

The best space pictures of 2025, from supernovae to moon landings

Related Posts

Early Retinal Fluid Drying May Extend Injection Gaps in AMD

Uneven Access to Biologics in Psoriasis, Study Shows

Early Prenatal Care on the Decline in the U.S., Says CDC Report

Fellow Nurses: What Can We Do About Rising Workplace Violence?

If Healthcare is Unaffordable, Stop Subsidizing It

FDA to Drop Two-Study Requirement for New Drug Approvals

Early Retinal Fluid Drying May Extend Injection Gaps in AMD

Uneven Access to Biologics in Psoriasis, Study Shows

Early Prenatal Care on the Decline in the U.S., Says CDC Report

Fellow Nurses: What Can We Do About Rising Workplace Violence?

If Healthcare is Unaffordable, Stop Subsidizing It

FDA to Drop Two-Study Requirement for New Drug Approvals

Trump Pressures FDA on Vaccines; Obesity Drug May Shed Too Much; Texas Hospital Sued

Four States and New York City Join WHO Outbreak Network

Categories

Archives